Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.530
-0.030 (-0.84%)
Apr 29, 2026, 9:54 AM EDT - Market open
MRVI Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | -130.77 | -144.85 | -119.03 | 220.21 | 182.04 | Upgrade
|
| Depreciation & Amortization | 60.47 | 56.87 | 48.78 | 38.1 | 33.54 | Upgrade
|
| Other Amortization | 1.65 | 2.9 | 2.93 | 2.79 | 2.68 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -11.25 | Upgrade
|
| Asset Writedown & Restructuring Costs | 84.6 | 166.15 | - | - | - | Upgrade
|
| Stock-Based Compensation | 30.17 | 49.42 | 34.59 | 18.67 | 10.46 | Upgrade
|
| Other Operating Activities | -95.72 | -110.4 | 61.11 | 301.29 | 327.74 | Upgrade
|
| Change in Accounts Receivable | 12.82 | 14.36 | 84.4 | -22.27 | -70.39 | Upgrade
|
| Change in Inventory | 8 | 0.38 | 0.65 | 9.46 | -21.57 | Upgrade
|
| Change in Accounts Payable | -7.35 | 0.72 | 5.28 | -1.58 | 0.68 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -7.12 | -67.85 | Upgrade
|
| Change in Other Net Operating Assets | -21.45 | -28.07 | 7.52 | -23.57 | -17.49 | Upgrade
|
| Operating Cash Flow | -57.57 | 7.47 | 126.22 | 535.98 | 368.57 | Upgrade
|
| Operating Cash Flow Growth | - | -94.09% | -76.45% | 45.42% | 142.18% | Upgrade
|
| Capital Expenditures | -13.15 | -29.66 | -65.55 | -17.09 | -14.85 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.55 | Upgrade
|
| Cash Acquisitions | -18.99 | - | -69.62 | -238.97 | - | Upgrade
|
| Divestitures | - | - | - | 0.62 | 119.96 | Upgrade
|
| Other Investing Activities | 0.73 | 5.34 | 12.87 | -12.17 | - | Upgrade
|
| Investing Cash Flow | -31.41 | -24.32 | -122.31 | -267.61 | 105.66 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 8.46 | - | Upgrade
|
| Long-Term Debt Repaid | -5.44 | -234.39 | -5.44 | -13.9 | -6 | Upgrade
|
| Net Debt Issued (Repaid) | -5.44 | -234.39 | -5.44 | -5.44 | -6 | Upgrade
|
| Issuance of Common Stock | - | - | - | 2.36 | 1.71 | Upgrade
|
| Other Financing Activities | -11.06 | -1.32 | -55.65 | -184.42 | -154.76 | Upgrade
|
| Financing Cash Flow | -16.5 | -235.71 | -61.09 | -187.5 | -159.05 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.03 | - | - | - | -0.09 | Upgrade
|
| Net Cash Flow | -105.51 | -252.56 | -57.18 | 80.87 | 315.09 | Upgrade
|
| Free Cash Flow | -70.72 | -22.19 | 60.67 | 518.89 | 353.72 | Upgrade
|
| Free Cash Flow Growth | - | - | -88.31% | 46.69% | 179.00% | Upgrade
|
| Free Cash Flow Margin | -38.07% | -8.56% | 21.00% | 58.76% | 44.26% | Upgrade
|
| Free Cash Flow Per Share | -0.49 | -0.16 | 0.46 | 2.03 | 1.37 | Upgrade
|
| Cash Interest Paid | 24.98 | 50.97 | 44.26 | 20.2 | 27.23 | Upgrade
|
| Cash Income Tax Paid | -0.56 | 0.67 | -2.99 | 23.03 | 22.47 | Upgrade
|
| Levered Free Cash Flow | -2.77 | -7.5 | 41.26 | 373.29 | 219.25 | Upgrade
|
| Unlevered Free Cash Flow | 12.45 | 19.42 | 67.02 | 383.26 | 235.48 | Upgrade
|
| Change in Working Capital | -7.98 | -12.61 | 97.84 | -45.08 | -176.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.